Gene · 3047
Papers4,047
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,047
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single cell transcription revealing key transcription factors in embryonic kidney development. | Mol Cell Biochem | 2025 | 40392427 | PubTator, text mining | PubMed |
| [A near-complete genomic analysis of aggregated outbreaks of norovirus subtype GⅡ.17[P17] in Beijing Chaoyang District from 2014 to 2024]. | Zhonghua Yu Fang Yi Xue Za Zhi | 2025 | 40374354 | PubTator, text mining | PubMed |
| Clinicohematological and molecular analysis of hemoglobin D syndrome and unknown variants in the hemoglobinopathy spectrum of Sindh, Pakistan. | PLoS One | 2025 | 40373022 | PubTator, text mining | PubMed |
| COVID-19 and blood group-related antigens: can natural anti-carbohydrate antibodies provide innate protection from symptomatic SARS-CoV-2 infection? | Front Med (Lausanne) | 2025 | 40370735 | PubTator, text mining | PubMed |
| Associations of acrylamide biomarkers with reproductive lifespan: A cross-sectional study in U.S. women. | Food Chem Toxicol | 2025 | 40334970 | PubTator, text mining | PubMed |
| RNA Editors Sculpt the Transcriptome During Terminal Erythropoiesis. | Res Sq | 2025 | 40313744 | PubTator, text mining | PubMed |
| Exploring pharmacogenetic factors influencing hydroxyurea response in tanzanian sickle cell disease patients: a genomic medicine approach. | Pharmacogenomics J | 2025 | 40268903 | PubTator, text mining | PubMed |
| RNA Editors Sculpt the Transcriptome During Terminal Erythropoiesis. | bioRxiv | 2025 | 40236006 | PubTator, text mining | PubMed |
| The induction effect of hydroxyurea and metformin on fetal globin in the K562 cell line. | Mol Med | 2025 | 40200166 | PubTator, text mining | PubMed |
| A common TBP-binding site mutation elevates fetal hemoglobin levels by competitive globin switching change in β-thalassemia. | Blood Adv | 2025 | 40197981 | PubTator, text mining | PubMed |
| Associations of exposure to acrylamide and glycidamide with psoriasis among adults: Findings from a population-based study. | Ecotoxicol Environ Saf | 2025 | 40187209 | PubTator, text mining | PubMed |
| Association of acrylamide exposure with markers of systemic inflammation and serum alpha-klotho concentrations in middle-late adulthood. | Front Public Health | 2025 | 40177073 | PubTator, text mining | PubMed |
| Advancing CRISPR genome editing into gene therapy clinical trials: progress and future prospects. | Expert Rev Mol Med | 2025 | 40160040 | PubTator, text mining | PubMed |
| Molecular Characterization of Complex Thalassemia with Multiple Variants in β-Globin Gene Cluster and the Identification of a Novel Structural Rearrangement in γ-Globin Gene. | Hemoglobin | 2025 | 40140352 | PubTator, text mining | PubMed |
| The future of ex vivo hematopoietic stem cell gene editing: what's next. | Regen Med | 2025 | 40137438 | PubTator, text mining | PubMed |
| Creating New Cis-Regulatory Elements of HBD to Reactivate Delta-Globin. | Hum Gene Ther | 2025 | 40114594 | PubTator, text mining | PubMed |
| Current and future treatments for sickle cell disease: From hematopoietic stem cell transplantation to in vivo gene therapy. | Mol Ther | 2025 | 40083162 | PubTator, text mining | PubMed |
| Distance matters: How protein regulators facilitate enhancer-promoter interactions and transcription. | Cell Genom | 2025 | 40081334 | PubTator, text mining | PubMed |
| A critique review of fetal hemoglobin modulators through targeting epigenetic regulators for the treatment of sickle cell disease. | Life Sci | 2025 | 40057227 | PubTator, text mining | PubMed |
| Evaluating Health-Related Quality of Life in Thalassemia: Low-Dose Thalidomide vs. Standard Care-Insights from a Comparative Study. | Hemoglobin | 2025 | 40038240 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3047/papers?page=6